Growth Metrics

LifeMD (LFMD) Equity Ratio (2016 - 2025)

LifeMD (LFMD) has disclosed Equity Ratio for 14 consecutive years, with 0.33 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 431.29% year-over-year to 0.33, compared with a TTM value of 0.33 through Dec 2025, up 431.29%, and an annual FY2025 reading of 0.33, up 431.29% over the prior year.
  • Equity Ratio was 0.33 for Q4 2025 at LifeMD, up from 0.02 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.47 in Q1 2022 and bottomed at 1.14 in Q3 2021.
  • Average Equity Ratio over 5 years is 0.09, with a median of 0.04 recorded in 2022.
  • The sharpest move saw Equity Ratio soared 1152.97% in 2022, then crashed 758.72% in 2023.
  • Year by year, Equity Ratio stood at 0.43 in 2021, then plummeted by 206.37% to 0.46 in 2022, then soared by 115.49% to 0.07 in 2023, then crashed by 238.59% to 0.1 in 2024, then soared by 431.29% to 0.33 in 2025.
  • Business Quant data shows Equity Ratio for LFMD at 0.33 in Q4 2025, 0.02 in Q3 2025, and 0.03 in Q2 2025.